Posttreatment liver function, but not baseline liver function stratifies patient survival after direct-acting antiviral treatment in decompensated cirrhosis with hepatitis C virus

被引：0

作者：

Yuki Tahata

Hayato Hikita

Satoshi Mochida

Nobuyuki Enomoto

Akio Ido

Hidekatsu Kuroda

Daiki Miki

Masayuki Kurosaki

Yoichi Hiasa

Ryotaro Sakamori

Norifumi Kawada

Taro Yamashita

Goki Suda

Hiroshi Yatsuhashi

Hitoshi Yoshiji

Naoya Kato

Taro Takami

Kazuhiko Nakao

Kentaro Matsuura

Yasuhiro Asahina

Yoshito Itoh

Ryosuke Tateishi

Yasunari Nakamoto

Eiji Kakazu

Shuji Terai

Masahito Shimizu

Yoshiyuki Ueno

Norio Akuta

Masanori Miyazaki

Yasutoshi Nozaki

Masayuki Kabayama

Satoshi Sobue

Akihiro Moriuchi

Tomokatsu Miyaki

Takahiro Kodama

Tomohide Tatsumi

Tomomi Yamada

Tetsuo Takehara

机构：

[1] Osaka University Graduate School of Medicine,Department of Gastroenterology and Hepatology

[2] Saitama Medical University,Department of Gastroenterology and Hepatology

[3] University of Yamanashi,First Department of Internal Medicine, Faculty of Medicine

[4] Kagoshima University Graduate School of Medicine and Dental Sciences,Digestive and Lifestyle Diseases, Department of Human and Environmental Sciences

[5] Iwate Medical University,Division of Gastroenterology and Hepatology, Department of Internal Medicine

[6] Hiroshima University,Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Sciences

[7] Musashino Red Cross Hospital,Department of Gastroenterology and Hepatology

[8] Ehime University Graduate School of Medicine,Department of Gastroenterology and Metabology

[9] Osaka Metropolitan University,Department of Hepatology, Graduate School of Medicine

[10] Kanazawa University Graduate School of Medicine,Department of Gastroenterology

[11] Hokkaido University,Department of Gastroenterology and Hepatology, Graduate School of Medicine

[12] National Hospital Organization Nagasaki Medical Center,Clinical Research Center

[13] Nara Medical University,Department of Gastroenterology

[14] Chiba University,Department of Gastroenterology, Graduate School of Medicine

[15] Yamaguchi University Graduate School of Medicine,Department of Gastroenterology and Hepatology

[16] Nagasaki University of Graduate School of Biomedical Sciences,Department of Gastroenterology and Hepatology

[17] Nagoya City University Graduate School of Medical Sciences,Department of Gastroenterology and Metabolism

[18] Tokyo Medical and Dental University,Department of Gastroenterology and Hepatology, Department of Liver Disease Control

[19] Kyoto Prefectural University of Medicine,Department of Molecular Gastroenterology and Hepatology, Graduate School of Medical Science

[20] The University of Tokyo,Department of Gastroenterology, Graduate School of Medicine

[21] University of Fukui,Second Department of Internal Medicine, Faculty of Medical Sciences

[22] National Center for Global Health and Medicine,The Research Center for Hepatitis and Immunology

[23] Niigata University,Division of Gastroenterology and Hepatology, Graduate School of Medicine and Dental Sciences

[24] Gifu University Graduate School of Medicine,Department of Gastroenterology/Internal Medicine

[25] Yamagata University,Department of Gastroenterology, Faculty of Medicine

[26] Toranomon Hospital,Department of Hepatology

[27] Osaka Police Hospital,Department of Gastroenterology

[28] Kansai Rosai Hospital,Department of Gastroenterology

[29] Kagoshima Prefectural Oshima Hospital,Department of Gastroenterology

[30] Kasugai Municipal Hospital,Department of Gastroenterology

[31] National Hospital Organization Kagoshima Medical Center,Department of Gastroenterology

[32] Toyokawa City Hospital,Department of Gastroenterology

[33] Osaka University Hospital,Department of Medical Innovation

来源：

Journal of Gastroenterology | 2023年 / 58卷

关键词：

DAA; Sofosbuvir; Velpatasvir; Prognosis; Child–Pugh score;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1211 / 1221

页数：10

共 50 条

[1] Posttreatment liver function, but not baseline liver function stratifies patient survival after direct-acting antiviral treatment in decompensated cirrhosis with hepatitis C virus
Tahata, Yuki
Hikita, Hayato
Mochida, Satoshi
Enomoto, Nobuyuki
Ido, Akio
Kuroda, Hidekatsu
Miki, Daiki
Kurosaki, Masayuki
Hiasa, Yoichi
Sakamori, Ryotaro
Kawada, Norifumi
Yamashita, Taro
Suda, Goki
Yatsuhashi, Hiroshi
Yoshiji, Hitoshi
Kato, Naoya
Takami, Taro
Nakao, Kazuhiko
Matsuura, Kentaro
Asahina, Yasuhiro
Itoh, Yoshito
Tateishi, Ryosuke
Nakamoto, Yasunari
Kakazu, Eiji
Terai, Shuji
Shimizu, Masahito
Ueno, Yoshiyuki
Akuta, Norio
Miyazaki, Masanori
Nozaki, Yasutoshi
Kabayama, Masayuki
Sobue, Satoshi
Moriuchi, Akihiro
Miyaki, Tomokatsu
Kodama, Takahiro
Tatsumi, Tomohide
Yamada, Tomomi
Takehara, Tetsuo
JOURNAL OF GASTROENTEROLOGY, 2023, 58 (12) : 1211 - 1221
[2] Post-treatment liver function, but not baseline liver function, predicts survival in hepatitis C virus patients with decompensated cirrhosis after direct-acting antiviral treatment
Tahata, Yuki
Hikita, Hayato
Mochida, Satoshi
Enomoto, Nobuyuki
Ido, Akio
Kuroda, Hidekatsu
Miki, Daiki
Kurosaki, Masayuki
Hiasa, Yoichi
Sakamori, Ryotaro
Kawada, Norifumi
Yamashita, Taro
Suda, Goki
Yatsuhashi, Hiroshi
Yoshiji, Hitoshi
Kato, Naoya
Takami, Taro
Nakao, Kazuhiko
Matsuura, Kentaro
Asahina, Yasuhiro
Itoh, Yoshito
Tateishi, Ryosuke
Nakamoto, Yasunari
Kakazu, Eiji
Terai, Shuji
Shimizu, Masahito
Ueno, Yoshiyuki
Akuta, Norio
Kodama, Takahiro
Tatsumi, Tomohide
Yamada, Tomomi
Takehara, Tetsuo
JOURNAL OF HEPATOLOGY, 2023, 78 : S1183 - S1183
[3] POSTTREATMENT CHILD - PUGH CLASS STRATIFIES PATIENT SURVIVAL AFTER DIRECT- ACTING ANTIVIRAL TREATMENT IN HEPATITIS C VIRUS - ASSOCIATED DECOMPENSATED CIRRHOSIS
Tahata, Yuki
Hikita, Hayato
Mochida, Satoshi
Enomoto, Nobuyuki
Ido, Akio
Kuroda, Hidekatsu
Miki, Daiki
Kurosaki, Masayuki
Hiasa, Yoichi
Sakamori, Ryotaro
Kawada, Norifumi
Yamashita, Taro
Suda, Goki
Yatsuhashi, Hiroshi
Yoshiji, Hitoshi
Kato, Naoya
Takami, Taro
Nakao, Kazuhiko
Matsuura, Kentaro
Asahina, Yasuhiro
Itoh, Yoshito
Tateishi, Ryosuke
Nakamoto, Yasunari
Kakazu, Eiji
Terai, Shuji
Shimizu, Masahito
Ueno, Yoshiyuki
Akuta, Norio
Kodama, Takahiro
Tatsumi, Tomohide
Yamada, Tomomi
Takehara, Tetsuo
HEPATOLOGY, 2023, 78 : S735 - S737
[4] THE IMPACT OF CHANGES IN LIVER FUNCTION AFTER DIRECT-ACTING ANTIVIRAL THERAPY ON THE PROGNOSIS IN HEPATITIS C VIRUS PATIENTS WITH DECOMPENSATED CIRRHOSIS
Tahata, Yuki
Hikita, Hayato
Mochida, Satoshi
Kawada, Norifumi
Enomoto, Nobuyuki
Yoshiji, Hitoshi
Kurosaki, Masayuki
Ido, Akio
Miki, Daiki
Kuroda, Hidekatsu
Sakamori, Ryotaro
Yatsuhashi, Hiroshi
Hiasa, Yoichi
Yamashita, Taro
Kato, Naoya
Nakao, Kazuhiko
Ueno, Yoshiyuki
Itoh, Yoshito
Suda, Goki
Takami, Taro
Matsuura, Kentaro
Tateishi, Ryosuke
Akuta, Norio
Kakazu, Eiji
Nakamoto, Yasunari
Asahina, Yasuhiro
Terai, Shuji
Shimizu, Masahito
Kodama, Takahiro
Tatsumi, Tomohide
Yamada, Tomomi
Takehara, Tetsuo
HEPATOLOGY, 2022, 76 : S356 - S358
[5] The impact of liver function improvement after direct-acting antiviral therapy on the outcome in hepatitis C virus patients with decompensated cirrhosis
Tahata, Yuki
Hikita, Hayato
Mochida, Satoshi
Enomoto, Nobuyuki
Kawada, Norifumi
Kurosaki, Masayuki
Ido, Akio
Yoshiji, Hitoshi
Miki, Daiki
Takikawa, Yasuhiro
Sakamori, Ryotaro
Hiasa, Yoichi
Yatsuhashi, Hiroshi
Nakao, Kazuhiko
Kato, Naoya
Ueno, Yoshiyuki
Itoh, Yoshito
Tateishi, Ryosuke
Suda, Goki
Takami, Taro
Matsuura, Kentaro
Yamashita, Taro
Akuta, Norio
Kanto, Tatsuya
Nakamoto, Yasunari
Asahina, Yasuhiro
Terai, Shuji
Shimizu, Masahito
Yamada, Ryoko
Kodama, Takahiro
Tatsumi, Tomohide
Yamada, Tomomi
Takehara, Tetsuo
JOURNAL OF HEPATOLOGY, 2022, 77 : S563 - S564
[6] Impact of new direct-acting antiviral drugs on hepatitis C virus-related decompensated liver cirrhosis
Essa, Mohamed
Sabry, Aliaa
Abdelsameea, Eman
Tharwa, El-Sayed
Salama, Mohsen
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (01) : 53 - 58
[7] Clinical course of hepatitis C virus-positive patients with decompensated liver cirrhosis in the era of direct-acting antiviral treatment
Maesaka, Kazuki
Sakamori, Ryotaro
Yamada, Ryoko
Tahata, Yuki
Oshita, Masahide
Hagiwara, Hideki
Sakakibara, Mitsuru
Tamura, Shinji
Hiramatsu, Naoki
Inada, Masami
Iio, Sadaharu
Ito, Toshifumi
Yakushijin, Takayuki
Doi, Yoshinori
Kodama, Takahiro
Hikita, Hayato
Tatsumi, Tomohide
Takehara, Tetsuo
HEPATOLOGY RESEARCH, 2021, 51 (05) : 517 - 527
[8] Baseline Factors Associated With Improvements in Decompensated Cirrhosis After Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection
El-Sherif, Omar
Jiang, Z. Gordon
Tapper, Elliot B.
Huang, K. C.
Zhong, Alex
Osinusi, Anu
Charlton, Michael
Manns, Michael
Afdhal, Nezam H.
Mukamal, Kenneth
McHutchison, John
Brainard, Diana M.
Terrault, Norah
Curry, Michael P.
GASTROENTEROLOGY, 2018, 154 (08) : 2111 - +
[9] Survival benefits of direct-acting antiviral therapy in patients with decompensated hepatitis C cirrhosis
Kim, W. R.
Osinusi, A.
Mannalithara, A.
Schall, R. A.
Brainard, D.
JOURNAL OF HEPATOLOGY, 2018, 68 : S84 - S84
[10] Severe hyponatremia after direct-acting antiviral treatment in a patient with virus C compensated liver cirrhosis and kidney transplant
Mihai, Catalina
Mihai, Bogdan Mircea
Dranga, Mihaela
Drug, Vasile Liviu
Covic, Adrian
Prelipcean, Cristina Cijevschi
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2018, 27 (02) : 203 - 204

← 1 2 3 4 5 →